Ascendis Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	616.04	559.54	392.16	444.77	446.27
Short-Term Investments	-	-	7.28	290.69	235.8
Cash & Short-Term Investments	616.04	559.54	399.44	735.46	682.06
Cash Growth	10.10%	40.08%	-45.69%	7.83%	-5.11%
Accounts Receivable	141.33	166.28	35.87	11.91	2.2
Other Receivables	16.36	11.16	19.9	13.72	20.99
Total Trade Receivables	157.7	177.44	55.77	25.63	23.19
Inventory	301.53	295.61	208.93	130.67	75.41
Other Current Assets	33.72	28.27	38.58	31.72	25.23
Total Current Assets	1,109	1,061	702.72	923.47	805.89
Net Property, Plant & Equipment	146.48	98.71	110.63	129.1	126.05
Other Intangible Assets	3.71	4.03	4.42	4.83	5.27
Long-Term Investments	32.53	13.58	5.69	30.42	145.91
Other Long-Term Assets	10.87	2.32	2.13	1.92	1.81
Total Assets	1,303	1,180	825.59	1,090	1,085
Accounts Payable	90.66	96.39	94.57	101.03	59.42
Current Portion of Long-Term Debt	486.53	491.54	421.27	11.63	7
Current Portion of Leases	-	-	-	13.79	-
Unearned Revenue	4.94	0.94	1.18	-	2.6
Other Current Liabilities	487.26	319	219.49	44.82	31.34
Total Current Liabilities	1,069	907.86	736.51	171.27	100.36
Long-Term Debt	385.25	365.08	223	387.56	97.97
Long-Term Leases	-	-	-	95.4	-
Other Long-Term Liabilities	10.75	12.26	11.78	172.16	2.96
Total Long-Term Liabilities	396	377.34	234.78	655.12	100.93
Total Liabilities	1,465	1,285	971.28	826.39	201.29
Common Stock	8.32	8.15	7.75	7.68	7.65
Retained Earnings	-171.14	-113.86	-153.45	255.67	875.99
Shareholders' Equity	-162.82	-105.71	-145.7	263.35	883.64
Total Liabilities & Equity	1,303	1,180	825.59	1,090	1,085
Total Debt	871.79	856.62	644.27	508.38	104.96
Net Cash (Debt)	-255.75	-297.07	-244.83	227.08	577.1
Net Cash Growth	-	-	-	-60.65%	-7.93%
Net Cash Per Share	-4.22	-5.13	-4.35	4.05	10.54
Book Value	-162.82	-105.71	-145.7	263.35	883.64
Book Value Per Share	-2.69	-1.83	-2.59	4.70	16.13
Tangible Book Value	-166.53	-109.73	-150.12	258.52	878.36
Tangible Book Value Per Share	-2.75	-1.90	-2.67	4.61	16.04

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q